Enlivex Therapeutics Ltd. (ENLV)

0.9799 +0.04 (+4.24%) USD  |  NASDAQ  |  Jan 20, 12:25
More

Enlivex Therapeutics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for ENLV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Compugen Ltd. Upgrade
Can-Fite BioPharma Ltd. --
BiomX, Inc. Upgrade
Nasus Pharma Ltd. --
Regentis Biomaterials Ltd. --